Alexis AF, Silverberg JI, Rice ZP, Armstrong AW, et al. Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type. Ann Allergy Asthma Immunol 2023 Nov 8:S1081-1206(23)01394.
PMID: 37949351